Early Immunosuppression and Rapid Recovery of Cardiogenic Shock in Multisystem Inflammatory Syndrome From Convalescent COVID-19.

Autor:	Coll MD; Division of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Yanamandala M; Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ferro EG; Division of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nutt CT; Division of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wei EQ; Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wang CJ; Division of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mehra MR; Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jazyk:	angličtina
Zdroj:	JACC. Case reports [JACC Case Rep] 2021 Sep 15; Vol. 3 (12), pp. 1403-1408.
DOI:	10.1016/j.jaccas.2021.06.045
Abstrakt:	A previously healthy 39-year-old man presented in cardiogenic shock with evidence of multisystem inflammatory syndrome of adults 2 months after a mild case of coronavirus disease 2019. He was treated with intravenous immunoglobulin and pulse-dose corticosteroids with rapid resolution of his symptoms and normalization of biventricular function. ( Level of Difficulty: Intermediate. ). Competing Interests: Dr Mehra has received personal fees from Abbott, Mesoblast, Janssen, Portola, Bayer, Triple Gene, and Baim Institute for Clinical Research; and is an advisory board member for NuPulseCV, Leviticus, and FineHeart. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2021 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu